Details
| Original language | English |
|---|---|
| Pages (from-to) | 796-798 |
| Number of pages | 3 |
| Journal | Nature Biotechnology |
| Volume | 39 |
| Publication status | Published - 7 Jul 2021 |
ASJC Scopus subject areas
- Biochemistry, Genetics and Molecular Biology(all)
- Biotechnology
- Chemical Engineering(all)
- Bioengineering
- Immunology and Microbiology(all)
- Applied Microbiology and Biotechnology
- Biochemistry, Genetics and Molecular Biology(all)
- Molecular Medicine
- Engineering(all)
- Biomedical Engineering
Cite this
- Standard
- Harvard
- Apa
- Vancouver
- BibTeX
- RIS
In: Nature Biotechnology, Vol. 39, 07.07.2021, p. 796-798.
Research output: Contribution to journal › Article › Research › peer review
}
TY - JOUR
T1 - Regulatory and intellectual property conundrums surrounding xenotransplantation
AU - Hoppe, Nils
AU - Cantz, Tobias
AU - Kwisda, Koko
N1 - Funding Information: This study was supported by the German Research Foundation through the excellence cluster ‘From Regenerative Biology to Reconstructive Therapies’ (REBIRTH; EXC 62/3) and through the CRC/TRR 127 ‘Biology of Xenogeneic Cell and Organ Transplantation: From Bench to Bedside’.
PY - 2021/7/7
Y1 - 2021/7/7
UR - http://www.scopus.com/inward/record.url?scp=85109827600&partnerID=8YFLogxK
U2 - 10.1038/s41587-021-00976-7
DO - 10.1038/s41587-021-00976-7
M3 - Article
VL - 39
SP - 796
EP - 798
JO - Nature Biotechnology
JF - Nature Biotechnology
SN - 1087-0156
ER -